Expression of CD44 and CD44v6 in primary cutaneous CD30 positive T-cell lymphoproliferative disorders

Journal of Cutaneous Pathology

Volumn 29, Issue 8, 2002, Pages 459-464

  Liang, Xiayuan ^a,b   Smoller, Bruce R ^c   Golitz, Loren E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V6 ANTIGEN; HERMES ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; METASTASIS; NONHODGKIN LYMPHOMA; PROGNOSIS; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD30; ANTIGENS, CD44; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE-CELL, KI-1; LYMPHOMATOID PAPULOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 0036736180     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2002.290803.x     Document Type: Article

References (36)

1. Expression and modulation of CD44 variant isoforms in humans
2. CD44 and cancer screening
3. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms
4. CD44: Structure, function, and association with the malignant process
5. CD44 - A molecule involved in leukocyte adherence and T cell activation
6. CD44: The hyaluronan receptor
7. CD44: A multitude of isoforms with diverse functions
8. CD44 and its interaction with extracellular matrix
9. Are CD44 variant isoforms involved in human tumor progression?
10. The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms
11. CD44: A variety of isoforms with functions in cell adhesion and tumor metastasis
12. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
13. Prevention of tumor metastasis formation by anti-variant CD44
14. Antigen differences between metastatic and non-metastatic BSp73 rat tumor variants characterized by monoclonal antibodies
15. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: Expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54)
16. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: Characterization and comparison with normal activated B cells and epithelial malignancies
17. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma
18. Activated human lymphocytes and aggressive non-Hodgkin's lymphoma express a homologue of the rat metastasis-associated variant of CD44
19. The World Health Organization classification of hematological malignancies report of the clinical advisory committee meeting, Alrlie House, Virginia, November 1997
20. EORTC classification for primary cutaneous lymphoma: A proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer
21. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes
22. CD44 variant expression in cutaneous T-cell lymphoma
23. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells
24. A unique phenotype of skin-associated lymphocytes in humans
25. CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor
26. Participation in normal immune responses of a metastasis-inducing splice variant of CD44
27. Pathology of malignant lymphomas
28. CD44v6 is a marker for systemic spread in cutaneous T-cell lymphomas
29. Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study on 47 cases
30. Immunophenotypic markers useful in the diagnosis and classification of hematopoietic neoplasms
31. Cytogenetic investigations in Hodgkin's disease. I. Involvement of specific chromosomes in marker formation
32. Chromosome 1p abnormalities in B non-Hodgkin's lymphoma
33. The spectrum of primary cutaneous CD30 (Ki-1) positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment
34. CD30/Ki-1-positive lymphoproliferative disorders of the skin. Clinicopathologic correlation and statistical analysis of 86 cases: A multicentric study from the EORTC cutaneous lymphoma project group
35. Allelic deletion at 9p21 in primary cutaneous CD30 (+) large cell lymphoma